CHD9-SPG7 Fusion FISH Probe
The CHD9-SPG7 Fusion FISH Probe is used to confirm a fusion of the CHD9 and SPG7 genes. The fusion of the CHD9 and SPG7 genes has been associated with Breast Invasive Carcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| CHD9-SPG7-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| CHD9-SPG7-20-RERE | 20 (40 μL) | 200 μL |
|
|
| CHD9-SPG7-20-REOR | 20 (40 μL) | 200 μL |
|
|
| CHD9-SPG7-20-REGO | 20 (40 μL) | 200 μL |
|
|
| CHD9-SPG7-20-REGR | 20 (40 μL) | 200 μL |
|
|
| CHD9-SPG7-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| CHD9-SPG7-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| CHD9-SPG7-20-OROR | 20 (40 μL) | 200 μL |
|
|
| CHD9-SPG7-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| CHD9-SPG7-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| CHD9-SPG7-20-GORE | 20 (40 μL) | 200 μL |
|
|
| CHD9-SPG7-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| CHD9-SPG7-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| CHD9-SPG7-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| CHD9-SPG7-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| CHD9-SPG7-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| CHD9-SPG7-20-GROR | 20 (40 μL) | 200 μL |
|
|
| CHD9-SPG7-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| CHD9-SPG7-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| CHD9-SPG7-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| CHD9-SPG7-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| CHD9-SPG7-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| CHD9-SPG7-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| CHD9-SPG7-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| CHD9-SPG7-20-AQAQ | 20 (40 μL) | 200 μL |
|
SPG7 Gene Summary
This gene encodes a mitochondrial metalloprotease protein that is a member of the AAA family. Members of this protein family share an ATPase domain and have roles in diverse cellular processes including membrane trafficking, intracellular motility, organelle biogenesis, protein folding, and proteolysis. Mutations in this gene cause autosomal recessive spastic paraplegia 7. Two transcript variants encoding distinct isoforms have been identified. [provided by RefSeq, Mar 2014]
Gene Name: SPG7, Paraplegin Matrix AAA Peptidase Subunit
Chromosome: CHR16: 89574804 -89624174
Locus: 16q24.3
CHD9 Gene Summary
The Chromodomain Helicase DNA Binding Protein 9 (CHD9) gene is located on chr16 :53088944-53361414 at 16q12.2.
Gene Name: Chromodomain Helicase DNA Binding Protein 9
Chromosome: CHR16: 53088944 -53361414
Locus: 16q12.2
Gene Diseases
The CHD9 SPG7 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Breast Invasive Carcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|